Skip to main content
. 2019 Feb;11(2):573–582. doi: 10.21037/jtd.2018.11.96

Figure 4.

Figure 4

Overall survival and 95% confidence interval of patients suffering from SPCs at a given time period after the diagnosis of NSCLC compared with those who survived to that period without SPC. (A) The overall survival and 95% confidence interval of patients suffering from SPCs during the first year after diagnosis of NSCLC compared with all patients without SPCs; (B) the overall survival and 95% confidence interval of patients suffering from SPCs during the third year after the diagnosis of NSCLC compared with all patients without SPCs; (C) the overall survival and 95% confidence interval of patients suffering from SPCs during the fifth year after the diagnosis of NSCLC compared with all patients without SPCs; (D) the overall survival and 95% confidence interval of patients suffering from SPCs during the ninth year after the diagnosis of NSCLC compared with all patients without SPCs. NSCLC, non-small cell lung cancer; SPC, second primary cancer.